Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Body Weight Adjusted Clopidogrel in CAD
NCT05657041Phase 3Unknown
- Start
- Apr 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clopidogrel in coronary artery disease (CAD). Status: unknown.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05657041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05657041.